project id: TCGA-LIHC; case submitter id: TCGA-KR-A7K7; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.27; rna integrity number: 7.8; age at index: 61; days to birth: -22587; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22587; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 951.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: Not Reported; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 461; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: f178cc5c-525a-418b-a868-fa6e7c50947c; sample submitter id: TCGA-KR-A7K7-01A; portion id: f5e4a41a-981e-4838-b031-71f63344a2be; portion submitter id: TCGA-KR-A7K7-01A-11; slide id: b4b09f85-874e-4825-a81d-b4b908ec60a0; slide submitter id: TCGA-KR-A7K7-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;